Literature DB >> 28507049

Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research.

Claudia Galuschka1, Rumyana Proynova1,2, Benjamin Roth1,2, Hellmut G Augustin3,4,5, Karin Müller-Decker6.   

Abstract

The devastating diseases of human cancer are mimicked in basic and translational cancer research by a steadily increasing number of tumor models, a situation requiring a platform with standardized reports to share model data. Models in Translational Oncology (MiTO) database was developed as a unique Web platform aiming for a comprehensive overview of preclinical models covering genetically engineered organisms, models of transplantation, chemical/physical induction, or spontaneous development, reviewed here. MiTO serves data entry for metastasis profiles and interventions. Moreover, cell lines and animal lines including tool strains can be recorded. Hyperlinks for connection with other databases and file uploads as supplementary information are supported. Several communication tools are offered to facilitate exchange of information. Notably, intellectual property can be protected prior to publication by inventor-defined accessibility of any given model. Data recall is via a highly configurable keyword search. Genome editing is expected to result in changes of the spectrum of model organisms, a reason to open MiTO for species-independent data. Registered users may deposit own model fact sheets (FS). MiTO experts check them for plausibility. Independently, manually curated FS are provided to principle investigators for revision and publication. Importantly, noneditable versions of reviewed FS can be cited in peer-reviewed journals. Cancer Res; 77(10); 2557-63. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28507049     DOI: 10.1158/0008-5472.CAN-16-3099

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia.

Authors:  Spas Dimitrov Markov; Daisy Gonzalez; Kamiya Mehla
Journal:  Curr Protoc Pharmacol       Date:  2020-12

2.  Genetic Ancestry Analysis Reveals Misclassification of Commonly Used Cancer Cell Lines.

Authors:  Stanley E Hooker; Leanne Woods-Burnham; K Sean Kimbro; Rick A Kittles; Madhavi Bathina; Stacy Lloyd; Priyatham Gorjala; Ranjana Mitra; Larisa Nonn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-02-20       Impact factor: 4.254

Review 3.  Preclinical mouse solid tumour models: status quo, challenges and perspectives.

Authors:  Nicolas Gengenbacher; Mahak Singhal; Hellmut G Augustin
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

4.  Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.

Authors:  Mercedes Rubio-Manzanares Dorado; Luis Miguel Marín Gómez; Daniel Aparicio Sánchez; Sheila Pereira Arenas; Juan Manuel Praena-Fernández; Juan Jose Borrero Martín; Francisco Farfán López; Miguel Ángel Gómez Bravo; Jordi Muntané Relat; Javier Padillo Ruiz
Journal:  World J Gastroenterol       Date:  2018-02-21       Impact factor: 5.742

Review 5.  Modeling Endometrial Cancer: Past, Present, and Future.

Authors:  Tom Van Nyen; Cristian P Moiola; Eva Colas; Daniela Annibali; Frédéric Amant
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

6.  Pan-cancer analysis reveals the role of long non-coding RNA LINC01614 as a highly cancer-dependent oncogene and biomarker.

Authors:  Dingding Wang; Hong Zhang; Xiaolian Fang; Dingfang Cao; Honggang Liu
Journal:  Oncol Lett       Date:  2020-05-20       Impact factor: 2.967

Review 7.  Metastasis and cachexia: alongside in clinics, but not so in animal models.

Authors:  Rebeka Tomasin; Ana Carolina Baptista Moreno Martin; Márcia Regina Cominetti
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-08-22       Impact factor: 12.910

Review 8.  Gynaecological cancers and their cell lines.

Authors:  Kristijan Skok; Lidija Gradišnik; Uroš Maver; Nejc Kozar; Monika Sobočan; Iztok Takač; Darja Arko; Rajko Kavalar
Journal:  J Cell Mol Med       Date:  2021-03-02       Impact factor: 5.310

Review 9.  Modeling neoplastic disease with spheroids and organoids.

Authors:  Michele Zanoni; Michela Cortesi; Alice Zamagni; Chiara Arienti; Sara Pignatta; Anna Tesei
Journal:  J Hematol Oncol       Date:  2020-07-16       Impact factor: 17.388

Review 10.  Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.

Authors:  Lorenzo Galluzzi; Ilio Vitale; Sarah Warren; Sandy Adjemian; Patrizia Agostinis; Aitziber Buqué Martinez; Timothy A Chan; George Coukos; Sandra Demaria; Eric Deutsch; Dobrin Draganov; Richard L Edelson; Silvia C Formenti; Jitka Fucikova; Lucia Gabriele; Udo S Gaipl; Sofia R Gameiro; Abhishek D Garg; Encouse Golden; Jian Han; Kevin J Harrington; Akseli Hemminki; James W Hodge; Dewan Md Sakib Hossain; Tim Illidge; Michael Karin; Howard L Kaufman; Oliver Kepp; Guido Kroemer; Juan Jose Lasarte; Sherene Loi; Michael T Lotze; Gwenola Manic; Taha Merghoub; Alan A Melcher; Karen L Mossman; Felipe Prosper; Øystein Rekdal; Maria Rescigno; Chiara Riganti; Antonella Sistigu; Mark J Smyth; Radek Spisek; John Stagg; Bryan E Strauss; Daolin Tang; Kazuki Tatsuno; Stefaan W van Gool; Peter Vandenabeele; Takahiro Yamazaki; Dmitriy Zamarin; Laurence Zitvogel; Alessandra Cesano; Francesco M Marincola
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.